GregoryMichaelLucasMD

Infectious Disease • Baltimore, MD

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Lucas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lucas' full profile

Already have an account?

Office
600 N Wolfe St
Baltimore, MD 21287
Phone+1 410-955-1725

Summary

hepatitis c

Education & Training

Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2001
Johns Hopkins UniversityResidency, Internal Medicine, 1994 - 1997
Duke University School of MedicineClass of 1994

Certifications & Licensure

MD State Medical License 1997 - 2026
American Board of Internal Medicine Infectious Disease

Clinical Trials

Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants Start of enrollment: 2005 Nov 01
Completed
Phase 2
Directly Administered HIV Therapy in Methadone Clinics Start of enrollment: 2006 Apr 01
Completed
Phase 2, Phase 3
Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations Start of enrollment: 2012 Oct 01
Completed
Not Applicable
Strategies to Improve the HIV Care Continuum Among Key Populations in India Start of enrollment: 2017 Oct 30
Completed
Not Applicable
Building on Needle Exchange to Optimize Prevention & Treatment Start of enrollment: 2018 Jun 22
Completed
Not Applicable
Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
Unknown status
Phase 4
Roles: Contact, Principal Investigator
Syringe Service Based Telemedicine and Social Network Driven HIV Prevention Service Implementation Start of enrollment: 2024 Aug 01
Not yet recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD.
Tarfa Verinumbe, Gregory M Lucas, Katie Zook, Brian Weir, Miles Landry
Drug and Alcohol Dependence Reports. 2024-12-01
Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic-based data.
Allison M McFall, Lakshmi Ganapathi, Mihili P Gunaratne, Aylur K Srikrishnan, Conjeevaram K Vasudevan
Addiction. 2024-11-27
A Road Map to Hepatitis C Elimination: Yesterday, Today, and Tomorrow.
Luis A Gonzalez Corro, Gregory M Lucas, Kathleen R Page
Open Forum Infectious Diseases. 2024-11-01

Journal Articles

The North-South Divide: Substance Use Risk, Care Engagement, and Viral Suppression Among Hospitalized HIV-Infected Patients in 11 U.S. Cities
Deborah K McMahon, Moupali Das, Wendy S Armstrong, Gregory M Lucas, Ank Nijhawan, Raul Mandler, Clinical Infectious Diseases
Clinical Pharmacology in HIV Therapy
Gregory M Lucas, Mohamed G Atta, Journal of the American Society of Nephrology

Other

Bacterial pulmonary infections in HIV-infected patients
Lucas GM
http://www.uptodate.com/contents/bacterial-pulmonary-infections-in-hiv-infected-patients
UpToDate, Wolters Kluwer Health - 2012-05-14

External Links

Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/gregory-lucas